Displaying 51–75 of 797 results for Packaging

Sort By Relevance Sort By Date
1 2 3 4 5 ...32

Achieving Sustainability in an Evolving Pharma Sector

(Article)

Life sciences companies look to utility savings, collaborative product development and serialization to go green according to Tom Egan, Vice President, Industry Services, PMMI, The Association for Packaging and Processing Technologies

How Data is Changing the Pharma Operations World

(Article)

Data is changing the pharma operations world by turning a buzzword into exponential impact.

The Clock is Ticking: How to Speed up Efforts to Meet Traceability Deadlines

(Article)

Digitization will require significant investment but will pay off in protection from counterfeits, cheaper recalls and improved production and inventory management

API Sourcing: Your Questions Answered

(Article)

Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains

Vendor Selection and Management From a Small Pharma Perspective

(Article)

Selecting the right vendor is critical for young companies. Here are six essential steps for making sure your company makes the right choice.

For Industry-Wide Digitalization, Think Small

(Article)

The needs of smaller companies must be addressed when discussing transformative processes

A Better Batch

(Article)

Today’s solid dose manufacturing reality still relies on skillful execution by operators

OEE Overview

(Article)

Industry experts weigh in on the application and value of Overall Equipment Effectiveness in pharma

China: Ripe for Drug Development Disruption

(Article)

China’s recent regulatory changes will positively impact global innovative drug development

Pharma Looks to Standardize Clinical Research Process

(Article)

Pharma leaders advocate standardized identification of investigational products to improve efficiency and safety in clinical trials

Atrium Innovations Modernizes Quality Management

(Article)

Atrium improves audits and complaints, change control, and product release processes with immediate access to information and operational visibility

The Digital Pharma Factory of Tomorrow

(Article)

Pharma companies that embrace a digital factory approach will see improvements in data availability, visibility and decision-making

The Rise of Hazard Chemistry in Drug Development

(Article)

Paul Moscrop, Process Engineering Manager at Sterling Pharma Solutions on the growing demand for hazardous chemistry brings new risks that require both chemistry and engineering expertise.

Product Focus: Avoiding a Mix-Up

(Article)

The latest tech and tricks for purchasing the best mixing equipment.

The Blockchain Boom

(Article)

How the emerging technology could be pharma's savior from costly regulations and counterfeit drugs.

Achieving Real-Time Results Without Infrastructure Investments

(Article)

How Pharmavite streamlined operations and boosted capacity from existing assets

Coming Clean: Amid Opioid Devastation, Industry and Regulators Scour for ...

(Article)

By many measures, the legal, regulatory and market fallout from opioids has just begun.

Biopharma CMO Consolidation: Opportunity or Obstacle?

(Article)

Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.

Contract Manufacturing & Development's Big Pharma Ascendency

(Article)

Contract Manufacturing & Development's Big Pharma Ascendency

Cutting-Edge Flexibility

(Article)

CDMOs perfect the art of survival in today’s multi-product world

Product Focus: Single-Use Technologies

(Article)

Product Focus: Single-Use Technologies

Staying on Track for Drug Safety

(Article)

Staying on Track for Drug Safety: Future electronic tracking and tracing system will shore up safety of drug supply chain.

EU FMD: The One-Year Countdown

(Article)

Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply – where does the industry stand?

Regulatory Intelligence Brief: 2017 FDA Overview

(Article)

All the major changes this year including guidance documents drafted and finalized, new legislation, other areas of interest and some tools to help you explore additional areas not covered herein but might be of interest to you; the impact of these changes is provided for some of the information.

Transforming Bioburden Risk with Digital Asset Intelligence

(Article)

Asset intelligence gives cGMP manufacturers a new way to harness the information they need to prove manufacturing compliance

Sort By Relevance Sort By Date
1 2 3 4 5 ...32